Kopran Ltd.
| BSE: 524280 | Sector: Health care |
| NSE: KOPRAN | ISIN Code: INE082A01010 |
| BSE 00:00 | 25 Oct | 201.00 |
-2.70 (-1.33%) |
OPEN
204.75 |
HIGH
207.90 |
LOW
194.50 |
| NSE 00:00 | 25 Oct | 203.10 |
-1.20 (-0.59%) |
OPEN
202.20 |
HIGH
210.00 |
LOW
194.10 |
| OPEN | 204.75 |
| PREVIOUS CLOSE | 203.70 |
| VOLUME | 11794 |
| 52-Week high | 262.00 |
| 52-Week low | 99.80 |
| P/E | 47.41 |
| Mkt Cap.(Rs cr) | 869 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Kopran Ltd. (KOPRAN) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Aurobindo Pharma | 685.35 | -9.65 | -1.39 | 15823.68 |
| Cipla | 901.90 | 5.90 | 0.66 | 13900.58 |
| Dr Reddy's Labs | 4675.45 | 39.35 | 0.85 | 13349.10 |
| Sun Pharma.Inds. | 813.00 | 0.45 | 0.06 | 12803.21 |
| Lupin | 927.60 | 8.75 | 0.95 | 11055.93 |
| Apollo Hospitals | 4166.65 | 135.15 | 3.35 | 9153.00 |
| Cadila Health. | 498.25 | -4.15 | -0.83 | 7790.40 |
| Glenmark Pharma. | 486.10 | -6.90 | -1.40 | 7567.93 |
| Alkem Lab | 3706.20 | -40.05 | -1.07 | 7219.68 |
| Divi's Lab. | 4996.80 | -87.00 | -1.71 | 6798.61 |
| Torrent Pharma. | 3084.55 | 116.15 | 3.91 | 6450.83 |
| Ipca Labs. | 2225.30 | -53.50 | -2.35 | 5114.11 |
| Alembic Pharma | 761.85 | -5.75 | -0.75 | 5051.44 |
| Laurus Labs | 553.90 | 17.15 | 3.20 | 4768.72 |
| Abbott India | 20073.80 | -177.95 | -0.88 | 4310.02 |
| Gland Pharma | 3723.45 | 29.80 | 0.81 | 3462.88 |
| Glaxosmi. Pharma | 1453.35 | -11.75 | -0.80 | 3193.74 |
| Granules India | 314.90 | -4.95 | -1.55 | 3134.98 |
| Sanofi India | 8275.85 | -91.80 | -1.10 | 2901.90 |
| Ajanta Pharma | 2167.85 | 14.35 | 0.67 | 2718.59 |
Quick Links for Kopran:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
